» Authors » Roland Walter

Roland Walter

Explore the profile of Roland Walter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 238
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vo P, Sandmaier B, Othus M, Ali N, Rodriguez-Arboli E, Orvain C, et al.
Res Sq . 2024 Nov; PMID: 39606437
Methodological advancements now allow older adults with AML to receive allografts although conflicting data exist regarding relative outcomes across age groups and benefits of different conditioning intensities. We retrospectively analyzed...
2.
Bohnenberger H, Kaderali L, Strobel P, Yepes D, Plessmann U, Dharia N, et al.
EMBO Mol Med . 2018 Aug; 10(9). PMID: 30097507
Patients with head-and-neck cancer can develop both lung metastasis and primary lung cancer during the course of their disease. Despite the clinical importance of discrimination, reliable diagnostic biomarkers are still...
3.
Walter R, Pan K, Doebele C, Comoglio F, Tomska K, Bohnenberger H, et al.
Blood . 2017 Jan; 129(5):598-608. PMID: 28064214
Burkitt lymphoma (BL) is an aggressive B-cell neoplasm that is currently treated by intensive chemotherapy in combination with anti-CD20 antibodies. Because of their toxicity, current treatment regimens are often not...
4.
Corso J, Pan K, Walter R, Doebele C, Mohr S, Bohnenberger H, et al.
Proc Natl Acad Sci U S A . 2016 May; 113(20):5688-93. PMID: 27155012
Burkitt's lymphoma (BL) is a highly proliferative B-cell neoplasm and is treated with intensive chemotherapy that, because of its toxicity, is often not suitable for the elderly or for patients...
5.
Mawad R, Becker P, Hendrie P, Scott B, Wood B, Dean C, et al.
Br J Haematol . 2015 Nov; 172(2):238-45. PMID: 26568032
Tosedostat, an oral aminopeptidase inhibitor, has synergy with cytarabine and hypomethylating agents. We performed a Phase II trial to determine rates of complete remission (CR) and survival using tosedostat with...
6.
Wanninger J, Bauer S, Eisinger K, Weiss T, Walter R, Hellerbrand C, et al.
Mol Cell Endocrinol . 2011 Nov; 349(2):248-54. PMID: 22118966
Chemokine-like receptor 1 (CMKLR1) ligands chemerin and resolvin E1 are suggested to have a role in non-alcoholic fatty liver disease (NAFLD). Here, expression of CMKLR1 in liver cells and NAFLD...
7.
Eisinger K, Bauer S, Schaffler A, Walter R, Neumann E, Buechler C, et al.
Exp Mol Pathol . 2011 Nov; 92(1):90-6. PMID: 22037282
Introduction: Chemerin stimulates migration of leukocytes to sites of inflammation and also increases inflammatory signaling in chondrocytes suggesting a function of chemerin in joint inflammation. Synovial fibroblasts (SF) are critically...
8.
Walter R, Wanninger J, Bauer S, Eisinger K, Neumeier M, Weiss T, et al.
Exp Mol Pathol . 2011 Sep; 91(3):740-4. PMID: 21946149
Connective tissue growth factor (CTGF) is induced in liver fibrosis and enhances the activity of transforming growth factor β (TGFβ). Recently we have shown that the hepatoprotective adipokine adiponectin downregulates...
9.
Neumeier M, Bauer S, Bruhl H, Eisinger K, Kopp A, Abke S, et al.
Cytokine . 2011 Sep; 56(3):573-80. PMID: 21890375
The adipokine adiponectin is well known to affect the function of immune cells and upregulation of CCL2 by adiponectin in monocytes/macrophages has already been reported. In the current study the...
10.
Bauer S, Neumeier M, Wanninger J, Walter R, Kopp A, Bala M, et al.
J Diabetes Complications . 2011 Aug; 25(6):377-81. PMID: 21813294
Increased serum resistin was found in rodent models of obesity and insulin resistance, whereas contradictory results have been obtained in human studies. In humans, resistin is primarily released by monocytes/macrophages,...